Publication Lists: 2020
| 1. | Igarashi, K., Uemura, T., and Kashiwagi, K.: Assessing acrolein for determination of the severity of brain stroke, dementia, renal failure and Sjögren’s syndrome. (Review article) [Abstract] Amino Acids 52, 119-127 (2020) |
| 2. | Nishimura, K., Okamoto, M., Sibue, R., Mizuta, T., Shibayama, T., Yoshino, T., Murakami, T., Yamaguchi, M., Tanaka, S., Toida, T., and Igarashi, K.: KLF4 is required for suppression of histamine synthesis by polyamines during bone marrow-derived mast cell differentiation. [Abstract] PLoS One 15, e0229744 (2020) |
| 3. | Uemura, T., Kanzaki, T., Ishizawa, K., Kashiwagi, K., and Igarashi, K.: Decrease of patients with brain infarction through evaluation of relative risk value of brain infarction by measurement of protein-conjugated acrolein, IL-6 and CRP in plasma together with age. [Abstract] Biomarkers J. 6, 1:65 (2020) |
| 4. | Sakamoto, A., Sahara, J., Kawai, G., Yamamoto, K., Ishihama, A., Uemura, T., Igarashi, K., Kashiwagi, K., and Terui, Y.: Cytotoxic mechanism of excess polyamines functions through translational repression of specific proteins encoded by the polyamine modulon. [Abstract] Int. J. Mol. Sci. 21, 2406 (2020) |
| 5. | Sakamoto, A., Terui, Y., Uemura, T., Igarashi, K., and Kashiwagi, K.: Polyamines regulate gene expression by stimulating translation of histone acetyltransferase mRNAs. [Abstract] J. Biol. Chem. 295, 8736-8745 (2020) |
| 6. | Sridharan, A., Shi, M., Leo, V. I., Subramaniam, N., Lim, T. C., Uemura, T., Igarashi, K., Tien Guan, S. T., Tan, N. S., Vardy, L. A.: The polyamine putrescine promotes human epidermal melanogenesis. [Abstract] J. Invest. Dermatol 140, 2032-2040 (2020) |
| 7. | Uju, Y., Kanzaki, T., Yamasaki, Y., Kondo, T., Nanasawa, H., Takeuchi, Y., Yanagisawa, Y., Kusanishi, S., Nakano, C., Enomoto, T., Sako, A., Yanai, H., Mimori, S., Igarashi, K., Takizawa, T., and Hayakawa, T.: Metabolic changes of Japanese schizophrenic patients transferred from hospitalization to outpatients. [Abstract] Glob. Health Med. 2, 178-183 (2020) |
| 8. | Sakamoto, A., Uemura, T., Terui, Y., Yoshida, M., Fukuda, K., Nakamura, T., Kashiwagi, K., and Igarashi, K.: Development of an ELISA for measurement of urinary 3-hydroxypropyl mercapturic acid (3-HPMA), the marker of stroke. [Abstract] Med. Sci. 8, 33 (2020) |
| 9. | Uju, Y., Kanzaki, T., Yamasaki, Y., Kondo, T., Nanasawa, H., Takeuchi, Y., Yanagisawa, Y., Kusanishi, S., Nakano, C., Enomoto, T., Sako, A., Yanai, H., Mishima, S., Mimori, S., Igarashi, K., Takizawa, T., and Hayakawa, T.: A cross-sectional study on metabolic similarities and differences between inpatients with schizophrenia and those with mood disorders. [Abstract] Ann. Gen. Psychiatry 19, 53 (2020) |
| 10. | Ko, K., Suzuki, T., Ishikawa, R., Hattori, N., Ito, R., Umehara, K., Furihata, T., Dohmae, N., Linhardt, R. J., Igarashi, K., Toida, T., and Higashi, K.: Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure. [Abstract] J. Biol. Chem. 295, 18614-18624 (2020) |
| 11. | Uemura, T., Suzuki, T., Ko, K., Nakamura, M., Dohmae, N., Sakamoto, A., Terui, Y., Toida, T., Kashiwagi, K., and Igarashi, K.: Structural change and degradation of cytoskeleton due to the acrolein conjugation with vimentin and actin during brain infarction. [Abstract] Cytoskeleton 77, 414-421 (2020) |
[和文]
| 1. | 五十嵐一衛: 蛋白質抱合アクロレイン、IL-6並びにCRP測定に基づく脳梗塞リスク評価による脳梗塞発症者数の減少 （未病と抗老化 第29巻 30-34, 2020年11月） |